Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK Otsuka also received good news, winning CHMP backing for schizophrenia treatment Abilify Maintena (aripiprazole). ... The medicine is an extended release injectable version of Abilify, which is marketed by Otsuka as part of a collaboration with Lundbeck.

Lundbeck losses deepen on EU fine

Lundbeck losses deepen on EU fine Other recent launches, such as alcoholism therapy Selincro (nalmefene) and depot antipsychotic Abilify Maintena (aripiprazole), are also off to a good start, said the company, although it did not reveal early ... Lundbeck also has two projects in phase

NICE gives final backing to drugs from Bayer, GSK and Otsuka

NICE gives final backing to drugs from Bayer, GSK and Otsuka Eylea, Revolade and Abilify all recommended for NHS use. NHS patients in England and Wales will have access to three new treatment options from Bayer, GSK and Otsuka after the drugs ... Abilify available for children with bipolar disorder. The trio of

Lundbeck to cut 50 jobs in Europe

Lundbeck to cut 50 jobs in Europe a once-monthly formulation of its Abilify (aripiprazole) antipsychotic; and new antidepressant, Brintellix (vortioxetine).

NICE backs Abilify for teenagers with bipolar disorder

NICE backs Abilify for teenagers with bipolar disorder The UK's National Institute for Health and Care Excellence (NICE) has backed the use of Otsuka's Abilify in teenagers with bipolar disorder. ... This deal was recently extended following the US FDA's decision to approve of Abilify Maintena an extended

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...

Infographics